AngelAlign Technology Reports Mid-2023 Results: Strong Domestic Case Growth While Investing in Global Expansion.


In August, AngelAlign Technology (6699.HK) reported mid-2023 financial results, highlighting strong year-on-year growth in revenue (8%) and clear aligner case shipments (23.6%) while investing in commercial infrastructure as part of its global expansion.

China: Clear aligner case shipments in China grew 11.4% year-on-year. China gross margin increased 130 bps year-on-year to 59.3%. The growth in China was driven by geographic expansion within China and higher than average growth in the kids and adolescent segments.

Global Expansion: In driving global expansion, the company established subsidiaries, hired sales teams, and successfully achieved regulatory approvals in a number of key developed markets. This investment resulted in an operating loss for the international business while driving an initial 9,400 clear aligner case shipments outside of China. Initial customer feedback has been positive particularly with regards to the innovative product portfolio, quality of the treatment planning, and the overall responsiveness of the organization.

Looking Forward: The global clear aligner market represents one of the fastest growing markets in oral health. With its twenty-year clear aligner history, experience in treating over one million 1 patients, broad clear aligner product portfolio, and high-quality treatment planning team, AngelAlign Technology is favorably positioned to drive top and bottom-line growth both in China and in key markets around the world.

*As of June 30, 2023, the total number of cases of any and all the products and services provided by all entities owned or controlled by Angelalign Technology Inc. has exceeded one million

View all articles